Stockscreener 앱 받기
55.29
1.41%
0.77
시간 외 거래:
55.30
0.010
+0.02%
Royalty Pharma Plc 주식(RPRX)의 최신 뉴스
Heartland Advisors Inc. Grows Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC (NASDAQ:RPRX) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
TD Asset Management Inc Has $9.19 Million Holdings in Royalty Pharma PLC $RPRX - MarketBeat
CenterBook Partners LP Has $2.71 Million Position in Royalty Pharma PLC $RPRX - MarketBeat
Transcript : Royalty Pharma plc Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 04 - marketscreener.com
RPRX: Synthetic royalties and R&D partnerships drive growth, with China and large pharma as key opportunities - TradingView
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance UK
Prudential PLC Decreases Stock Position in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) director receives 4,545 share unit award - Stock Titan
Royalty Pharma (RPRX) director awarded 4,545 restricted stock units in equity grant - Stock Titan
Director Ted Love receives 4,545 RSUs at Royalty Pharma (RPRX) - Stock Titan
Director at Royalty Pharma (RPRX) receives 4,545 restricted stock units grant - Stock Titan
Royalty Pharma (RPRX) director Carole Ho awarded 4,545 restricted shares - Stock Titan
Royalty Pharma (RPRX) awards 4,545 RSUs to board director - Stock Titan
Royalty Pharma (RPRX) director awarded 4,545 RSUs under 2020 equity plan - Stock Titan
Royalty Pharma (RPRX) director Bonnie Bassler awarded 4,545 RSUs, raising holdings to 78,492 shares - Stock Titan
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week HighTime to Buy? - MarketBeat
Capital International Inc. CA Acquires 58,030 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Stock Position Increased by Brandywine Global Investment Management LLC - MarketBeat
ROYALTY PHARMA PLC- CL A (RPRX) Stock Chart - ChartMill
Royalty Pharma plc Announces Resignation of Errol Bento Jose Trinidade De Souza as Director, Effective June 4, 2026 - marketscreener.com
Los Angeles Capital Management LLC Purchases 212,294 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Acquired by Capital International Ltd. CA - MarketBeat
Capital International Sarl Purchases 166,334 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by Capital International Investors - MarketBeat
Capital Group Investment Management PTE. LTD. Has $2.53 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Cash from operating activities of Royalty Pharma Plc Class A – XETR:RPD - TradingView
Operating expenses (excl. COGS) of Royalty Pharma Plc Class A – XETR:RPD - TradingView
Non-controlling/minority interest of Royalty Pharma Plc Class A – XETR:RPD - TradingView
(RPRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Norges Bank Invests $131.92 Million in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma to present at Goldman Sachs Healthcare Conference on June 9, 2026 - Pluang
Royalty Pharma to present at the Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
Royalty Pharma (RPRX) shareholders back directors, pay and share issuance powers at 2026 AGM - Stock Titan
Nomura Asset Management Co. Ltd. Boosts Stock Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma PLC $RPRX Shares Purchased by BNP Paribas Financial Markets - MarketBeat
Royalty Pharma (RPRX) Q1 2026 Earnings Transcript - AOL.com
Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma plc (RPRX) Stock Analysis: Evaluating Its 6.26% Potential Upside and Strong Buy Ratings - DirectorsTalk Interviews
Royalty Pharma Secures New $1.8 Billion Credit Facility - The Globe and Mail
Royalty Pharma signs $500M co-development agreement with J&J - MSN
Royalty Pharma stock hits 52-week high at 54.82 USD By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at 54.82 USD - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX - MarketBeat
Legal & General Group Plc Has $119.32 Million Stake in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares - Investing.com India
Royalty Pharma EVP & CFO Coyne sells $3.48 million in shares By Investing.com - Investing.com South Africa
Royalty Pharma (RPRX) CFO-linked entity sells 64,399 shares under 10b5-1 plan - Stock Titan
Royalty Pharma plc Enters into Revolving Credit Agreement - marketscreener.com
Royalty Pharma (NASDAQ: RPRX) renews $1.8B unsecured revolver to 2031 - Stock Titan
Royalty Pharma Plc Hits New 52-Week High of $54.74 - Markets Mojo
Royalty Pharma Plc Hits New 52-Week High at $54.63 - Markets Mojo
How Investors May Respond To Royalty Pharma (RPRX) Strong Q1 Royalties And Expanding Biotech Partnerships - Sahm
Affiliates file to sell RPRX shares amid recent tranche sales (NASDAQ: RPRX) - Stock Titan
10% Of This Royalty Pharma Insider's Holdings Were Sold - 富途牛牛
Responsive Playbooks and the RPRX Inflection - Stock Traders Daily
HighTower Advisors LLC Grows Holdings in Royalty Pharma PLC $RPRX - MarketBeat
Royalty Pharma (RPRX) Valuation Check After Strong Share Price Momentum And Royalty Growth Potential - Yahoo Finance
Royalty Pharma plc (RPRX) Stock Analysis: Exploring Its 8.72% Upside and Strategic Biopharma Investments - DirectorsTalk Interviews
3.93%
1.27%
자본화:
|
볼륨(24시간):